Ghent University Academic Bibliography

Your filters: cql: author="Beiske, Klaus" or (type any "bookEditor issueEditor" and editor="Beiske, Klaus")

Add to list
- Journal Article
- A1
- open access
Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) high-risk neuroblastoma trial (HR-NBL1)

Angela Bellini, Ulrike Pötschger, Virginie Bernard, Eve Lapouble, Sylvain Baulande, Peter F. Ambros, Nathalie Auger, Klaus Beiske, Marie Bernkopf, David R. Betts, et al.

(2021) JOURNAL OF CLINICAL ONCOLOGY. 39(30). p.3377-3390
Add to list
- Journal Article
- A1
- open access
11q deletion or ALK activity curbs DLG2 expression to maintain an undifferentiated state in neuroblastoma

Joachim Tetteh Siaw, Niloufar Javanmardi, Jimmy Van den Eynden (UGent) , Dan Emil Lind, Susanne Fransson, Angela Martinez-Monleon, Anna Djos, Rose-Marie Sjöberg, Malin Östensson, Helena Carén, et al.

(2020) CELL REPORTS. 32(12).
Add to list
- Journal Article
- A1
- open access
N-Cadherin in neuroblastoma disease : expression and clinical significance

Tim Lammens (UGent) , Katrien Swerts (UGent) , Lara Derycke (UGent) , Annemie De Craemer (UGent) , Sara De Brouwer (UGent) , Katleen De Preter (UGent) , Nadine Van Roy (UGent) , Jo Vandesompele (UGent) , Franki Speleman (UGent) , Jan Philippé (UGent) , et al.

(2012) PLOS ONE. 7(2).
Add to list
- Conference Paper
- C3
The prognostic value of semi-quantitative 123I MIBG scintigraphy at diagnosis in high risk neuroblastoma: validation of the SIOPEN score method

Ruth Ladenstein, Ulrike Poetschger, Ariane Boubaker, Zvi Bar-Sever, Brent Drake, Anton Staudenherz, Maria Rita Castellani, Bieke Lambert (UGent) , Katheryn Grange, Penelope Brock, et al.

(2011) PEDIATRIC BLOOD & CANCER. 57(5). p.732-733
Add to list
A multilocus technique for risk evaluation of patients with neuroblastoma

Inge M Ambros, Bettina Brunner, Gerhard Aigner, Clare Bedwell, Klaus Beiske, Jean Bénard, Nick Bown, Valerie Combaret, Jerome Couturier, Raffaella Defferrari, et al.

(2011) CLINICAL CANCER RESEARCH. 17(4). p.792-804
Add to list
Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification

Sara De Brouwer (UGent) , Katleen De Preter (UGent) , Candy Kumps (UGent) , Piotr Zabrocki, Michael Porcu, Ellen M Westerhout, Arjan Lakeman, Jo Vandesompele (UGent) , Jasmien Hoebeeck (UGent) , Tom Van Maerken (UGent) , et al.

(2010) CLINICAL CANCER RESEARCH. 16(17). p.4353-4362
Add to list
Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

Joëlle Vermeulen (UGent) , Katleen De Preter (UGent) , Arlene Naranjo, Liesbeth Vercruysse (UGent) , Nadine Van Roy (UGent) , Jan Hellemans (UGent) , Katrien Swerts (UGent) , Sophie Bravo, Paolo Scaruffi, Gian Paolo Tonini, et al.

(2009) LANCET ONCOLOGY. 10(7). p.663-671

Academic Bibliography

Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) high-risk neuroblastoma trial (HR-NBL1)

11q deletion or ALK activity curbs DLG2 expression to maintain an undifferentiated state in neuroblastoma

N-Cadherin in neuroblastoma disease : expression and clinical significance

The prognostic value of semi-quantitative 123I MIBG scintigraphy at diagnosis in high risk neuroblastoma: validation of the SIOPEN score method

A multilocus technique for risk evaluation of patients with neuroblastoma

Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification

Predicting outcomes for children with neuroblastoma using a multigene-expression signature: a retrospective SIOPEN/COG/GPOH study

Contents

Support

Contact